Investor Relations

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.

Latest Financial Results

Q2 2020

Quarter Ended Jun 30, 2020

Stock Information

Company Overview

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.

Corporate Presentation

Corporate Presentation

Download Corporate Presentation

Leadership

Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information

Company

Kane Biotech Inc.
162-196 Innovation Drive
Winnipeg, Manitoba R3T 2N2
Canada
T: 204.477.7592
ir@kanebiotech.com

Investor Relations

Harbor Access LLC
Graham Farrell
Managing Partner
130 King St. W
Suite 1900
Toronto, ON
T: (416) 842 9003
graham.farrell@harboraccessllc.com

Jonathan Paterson
Partner
320 Post Rd.
Darien, CT 06820
USA
T: (203) 862 0492
jonathan.paterson@harboraccessllc.com

Transfer Agent

Canadian Stock Transfer Company Inc.
600, 333 – 7th Avenue S.W.
Calgary, Alberta T2P 2Z1